Ditchcarbon
  • Contact
  1. Organizations
  2. China Biopharmaceuticals Holdings, Inc.
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

Pharmaceutical Preparation Manufacturing
CN
updated 7 months ago

China Biopharmaceuticals Holdings, Inc.

Company website

China Biopharmaceuticals Holdings, Inc., a prominent player in the biopharmaceutical industry, is headquartered in China (CN) and operates extensively across various regions. Founded in the early 2000s, the company has achieved significant milestones, establishing itself as a leader in the development and production of innovative biopharmaceutical products. Specialising in the research, manufacturing, and distribution of therapeutic drugs, China Biopharmaceuticals focuses on areas such as oncology, infectious diseases, and autoimmune disorders. Its unique portfolio includes monoclonal antibodies and recombinant proteins, which are designed to address unmet medical needs. With a strong market position, China Biopharmaceuticals Holdings has garnered recognition for its commitment to quality and innovation, contributing to advancements in healthcare both domestically and internationally. The company continues to expand its influence, striving to improve patient outcomes through cutting-edge biopharmaceutical solutions.

DitchCarbon Score

How does China Biopharmaceuticals Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

China Biopharmaceuticals Holdings, Inc.'s score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.

17%

Let us know if this data was useful to you

China Biopharmaceuticals Holdings, Inc.'s reported carbon emissions

China Biopharmaceuticals Holdings, Inc., headquartered in CN, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As a current subsidiary, China Biopharmaceuticals Holdings, Inc. may inherit climate-related initiatives and targets from its parent organisation. However, no specific data or targets have been cascaded from the parent company, which limits the available information on their climate commitments. In the broader context of the biopharmaceutical industry, companies are increasingly recognising the importance of sustainability and are often encouraged to adopt science-based targets to mitigate climate impact. Without specific emissions data or reduction initiatives, it remains unclear how China Biopharmaceuticals Holdings, Inc. aligns with these industry trends.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. China Biopharmaceuticals Holdings, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for China Biopharmaceuticals Holdings, Inc. is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

China Biopharmaceuticals Holdings, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Innovent Biologics

CN
•
Pharmaceutical Preparation Manufacturing
Updated 22 days ago

Fosun Pharma

CN
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Beigene

CN
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Cspc Pharmaceutical

HK
•
Pharmaceutical Preparation Manufacturing
Updated less than a minute ago

Hengrui Pharma

CN
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

China Resources Double-Crane Pharmaceutical Co.,Ltd.

CN
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251005.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy